Philadelphia-based Thomas Jefferson University, owner of Jefferson Health, recorded an operating loss of $29.3 million (-0.3% operating margin) through the first three quarters of fiscal 2025, compared to an operating loss of $30.2 million (-0.4% margin) during the same period last year, according to its May 15 financial report.
Four things to know:
1. Jefferson’s total operating revenue and expenses through the nine months ended March 31 were each about $4 billion higher than the same period last year, primarily due to its Aug. 1 merger with Allentown, Pa.-based Lehigh Valley Health.
2. Jefferson’s operating revenue through the third quarter of 2025 was $11.3 billion, 5.7% above budget expectations. Net patient service revenue was 3.3% above budget, insurance premium revenue was 6.4% above, and other revenue was 45.4% above, driven mainly by higher ambulatory pharmacy revenue.
3. Operating expenses totaled $11.4 billion through the first three quarters of the fiscal year, 6.2% above budget expectations. The overage was driven by supply costs (12.4% above budget), drugs (24.9% above) and insurance services medical expenses (22.2% above).
4. Jefferson had 117.3 days cash on hand as of March 31, down from 140.4 on June 30.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
